Evolution of Cryptococcal Antigen Testing: What is new?

Curr Fungal Infect Rep

Infectious Diseases Institute, Mulago Hill Road, Makerere University, Uganda.; Department of Medicine, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, USA.; School of Medicine, College of Health Sciences, Makerere University.

Published: June 2016

Over the last decade, an upsurge in both the frequency and severity of fungal infections due to the HIV/AIDS epidemic and the use of immunosuppressive therapy has occurred. Even diagnostic methods like culture and microscopy, which have low sensitivity and longer turn-around-times are not widely available, leading to delays in timely antifungal therapy and detrimental patient outcomes. The evolution of cryptococcal antigen (CrAg) testing to develop inexpensive and more sensitive methods to detect cryptococcal antigen is significant. These newer tests employ immunoassays as part of point-of-care platforms, which do not require complex laboratory infrastructure and they have the potential to detect early disease and reduce time to diagnosis of cryptococcal infection. Advocacy for widely available and efficacious life-saving antifungal treatment should be the only remaining challenge.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858186PMC
http://dx.doi.org/10.1007/s12281-016-0256-3DOI Listing

Publication Analysis

Top Keywords

cryptococcal antigen
12
evolution cryptococcal
8
antigen testing
4
testing new?
4
new? decade
4
decade upsurge
4
upsurge frequency
4
frequency severity
4
severity fungal
4
fungal infections
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!